Fundamental Analysis of INVACARE CORP(NYSE:IVC) stock

Fundamental Rating

We assign a fundamental rating of 1 out of 10 to IVC. IVC was compared to 195 industry peers in the Health Care Equipment & Supplies industry. IVC may be in some trouble as it scores bad on both profitability and health. IVC has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year IVC has reported negative net income.

IVC had a negative operating cash flow in the past year.

In the past 5 years IVC always reported negative net income.

In multiple years IVC reported negative operating cash flow during the last 5 years.

1.2 Ratios

IVC has negative profitability rations, so we won't be analyzing them here.

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 24.21%, IVC is not doing good in the industry: 77.78% of the companies in the same industry are doing better.

In the last couple of years the Gross Margin of IVC has remained more or less at the same level.

The Profit Margin and Operating Margin are not available for IVC so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	24.21%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.15%

GM growth 5Y0.24%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

IVC does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, IVC has more shares outstanding

Compared to 1 year ago, IVC has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.90, we must say that IVC is in the distress zone and has some risk of bankruptcy.

IVC has a Altman-Z score of 0.90. This is comparable to the rest of the industry: IVC outperforms 47.22% of its industry peers.

IVC has a Debt/Equity ratio of 4.82. This is a high value indicating a heavy dependency on external financing.

IVC has a Debt to Equity ratio of 4.82. This is amonst the worse of the industry: IVC underperforms 88.43% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	4.82
Debt/FCF	N/A
Altman-Z	0.9

ROIC/WACCN/A

WACC5.71%

2.3 Liquidity

A Current Ratio of 1.32 indicates that IVC should not have too much problems paying its short term obligations.

The Current ratio of IVC (1.32) is worse than 85.65% of its industry peers.

A Quick Ratio of 0.78 indicates that IVC may have some problems paying its short term obligations.

With a Quick ratio value of 0.78, IVC is not doing good in the industry: 87.96% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	1.32
Quick Ratio	0.78

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

IVC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -137.21%.

IVC shows a decrease in Revenue. In the last year, the revenue decreased by -9.61%.

The Revenue has been decreasing by -3.59% on average over the past years.

EPS 1Y (TTM)-137.21%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q-666.67%

Revenue 1Y (TTM)-9.61%

Revenue growth 3Y-3.55%

Revenue growth 5Y-3.59%

Revenue growth Q2Q-23.99%

3.2 Future

IVC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.14% yearly.

IVC is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.30% yearly.

EPS Next Y-309.94%

EPS Next 2Y-41.08%

EPS Next 3Y1.14%

EPS Next 5YN/A

Revenue Next Year-16.76%

Revenue Next 2Y-8.92%

Revenue Next 3Y-0.3%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IVC. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IVC. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-41.08%

EPS Next 3Y1.14%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for IVC!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

INVACARE CORP

NYSE:IVC (1/31/2023, 7:04:00 PM)

Premarket: 0.53 -0.13 (-19.67%)

0.6598

-0.02 (-2.25%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap24.91M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	24.21%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover1.04

Health

		Industry Rank	Sector Rank
Debt/Equity	4.82
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	1.32
Quick Ratio	0.78
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-137.21%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y-309.94%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-9.61%

Revenue growth 3Y-3.55%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

INVACARE CORP (IVC)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens